Guggenheim Capital’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-52,980
Closed -$2.43M 2320
2018
Q3
$2.43M Buy
52,980
+3,991
+8% +$183K 0.02% 1130
2018
Q2
$2.9M Buy
48,989
+7,505
+18% +$444K 0.02% 1027
2018
Q1
$2.82M Buy
41,484
+5,359
+15% +$365K 0.01% 1393
2017
Q4
$3.57M Sell
36,125
-6,324
-15% -$625K 0.01% 1235
2017
Q3
$5.08M Sell
42,449
-3,501
-8% -$419K 0.01% 1052
2017
Q2
$4.02M Sell
45,950
-12,031
-21% -$1.05M 0.01% 1142
2017
Q1
$2.16M Buy
57,981
+250
+0.4% +$9.3K 0.01% 1607
2016
Q4
$1.77M Buy
57,731
+5,784
+11% +$178K 0.01% 1777
2016
Q3
$3.48M Buy
51,947
+40,392
+350% +$2.71M 0.01% 1238
2016
Q2
$344K Sell
11,555
-57,377
-83% -$1.71M ﹤0.01% 2503
2016
Q1
$2.03M Buy
68,932
+15,217
+28% +$447K 0.01% 1559
2015
Q4
$4.21M Buy
53,715
+13,528
+34% +$1.06M 0.01% 1100
2015
Q3
$3.03M Sell
40,187
-52,038
-56% -$3.92M 0.01% 1309
2015
Q2
$10.8M Buy
92,225
+44,255
+92% +$5.17M 0.03% 800
2015
Q1
$11.3M Buy
47,970
+997
+2% +$235K 0.03% 806
2014
Q4
$8.89M Buy
46,973
+13,348
+40% +$2.53M 0.02% 877
2014
Q3
$8.02M Sell
33,625
-34,296
-50% -$8.18M 0.02% 978
2014
Q2
$4.48M Buy
67,921
+8,061
+13% +$532K 0.01% 1231
2014
Q1
$6.23M Buy
59,860
+13,016
+28% +$1.36M 0.02% 1028
2013
Q4
$4.85M Buy
+46,844
New +$4.85M 0.01% 1098